Mesoblast Limited (OTCMKTS:MEOBF) Short Interest Up 25.1% in November

Mesoblast Limited (OTCMKTS:MEOBF) saw a significant growth in short interest in the month of November. As of November 30th, there was short interest totalling 13,699,800 shares, a growth of 25.1% from the November 15th total of 10,952,000 shares. Based on an average trading volume of 65,200 shares, the short-interest ratio is presently 210.1 days.

Mesoblast Price Performance

MEOBF remained flat at $1.03 during midday trading on Monday. The company’s stock had a trading volume of 4,156,982 shares, compared to its average volume of 74,003. The firm has a fifty day simple moving average of $1.06 and a two-hundred day simple moving average of $0.84. Mesoblast has a 12-month low of $0.10 and a 12-month high of $1.41.

About Mesoblast

Mesoblast Limited engages in the development of regenerative medicine products in Australia, the United States, Singapore, and Switzerland. The company offers products in the areas of cardiovascular, spine orthopedic disorder, oncology, hematology, and immune-mediated and inflammatory diseases. Its proprietary regenerative medicine technology platform is based on specialized cells known as mesenchymal lineage cells.